Life context of pharmacological academic performance enhancement among university students - A qualitative approach

BMC Medical Ethics

Volumn 15, Issue 1, 2014, Pages

  Hildt, Elisabeth ^a   Lieb, Klaus ^b   Franke, Andreas Günter ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Academic performance enhancement; Attitudes; Cognitive enhancement; Ethics; Life impact; Stimulants; University students

Indexed keywords

AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; NOOTROPIC AGENT;

ADDICTION; ADULT; ARTICLE; COGNITION; DRUG EFFECT; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MOTIVATION; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; STUDENT; UNIVERSITY;

ADULT; AMPHETAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MOTIVATION; NOOTROPIC AGENTS; QUALITATIVE RESEARCH; STUDENTS; SUBSTANCE-RELATED DISORDERS; UNIVERSITIES;

EID: 84898036676     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/1472-6939-15-23     Document Type: Article

References (35)

1. Smart drugs "as common as coffee": media hype about neuroenhancement. Partridge BJ, Bell SK, Lucke JC, Yeates S, Hall WD, PLoS One 2011 6 28416 10.1371/journal.pone.0028416 22140584
2. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. de Jongh R, Bolt I, Schermer M, Olivier B, Neurosci Biobehav Rev 2008 32 760 776 10.1016/j.neubiorev.2007.12.001 18295885
3. Poll results: look who's doping. Maher B, Nature 2008 452 674 675 10.1038/452674a 18401370
4. Pharmacological Neuroenhancement: Substances and Epidemiology. Franke AG, Lieb K, Cognitive Enhancement-An Interdisciplinary Perspective Heidelberg: Springer Verlag, Hildt E, Franke AG, 2013 17 27
5. Modafinil and methylphenidate for neuroenhancement in healthy individuals: a systematic review. Repantis D, Schlattmann P, Laisney O, Heuser I, Pharmacol Res 2010 62 187 206 10.1016/j.phrs.2010.04.002 20416377
6. Modafinil: a review of neurochemical actions and effects on cognition. Minzenberg MJ, Carter CS, Neuropsychopharmacology 2008 33 1477 1502 10.1038/sj.npp.1301534 17712350
7. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Smith ME, Farah MJ, Psychol Bull 2011 137 717 741 21859174
8. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people. Ilieva I, Boland J, Farah MJ, Neuropharmacology 2013 64 496 505 22884611
9. What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement. Franke AG, Lieb K, Hildt E, PLoS One 2012 7 40047 10.1371/journal.pone.0040047 22768218
10. [Characteristics of university students using stimulants for cognitive enhancement: a pilot study]. Franke AG, Schwarze CE, Christmann M, Bonertz C, Hildt E, Lieb K, Psychiatr Prax 2012 39 174 180 22318482
11. Enhancement stimulants: perceived motivational and cognitive advantages. Ilieva IP, Farah MJ, Front Neurosci 2013 7 198 24198755
12. Just how cognitive is "Cognitive Enhancement"? On the significance of emotions in university students' experiences with study drugs. Vrecko S, AJOB Neurosci 2013 4 4 12 10.1080/21507740.2012.740141 23486311
13. From attention-deficit/hyperactivity disorder to medical stimulant use to the diversion of prescribed stimulants to non-medical stimulant use: connecting the dots. Poulin C, Addiction 2007 102 740 751 10.1111/j.1360-0443.2007.01758.x 17506151
14. Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review. Kollins SH, MacDonald EK, Rush CR, Pharmacol Biochem Behav 2001 68 611 627 10.1016/S0091-3057(01)00464-6 11325419
15. Smart drugs for cognitive enhancement: ethical and pragmatic considerations in the era of cosmetic neurology. Cakic V, J Med Ethics 2009 35 611 615 10.1136/jme.2009.030882 19793941
16. Academic doping or Viagra for the brain? The history of recreational drug use and pharmacological enhancement can provide insight into these uses of neuropharmaceuticals. Lucke JC, Bell SK, Partridge BJ, Hall WD, EMBO Rep 2011 12 197 201 10.1038/embor.2011.15 21311560
17. Student perceptions of methylphenidate abuse at a public liberal arts college. Babcock Q, Byrne T, J Am Coll Health 2000 49 143 145 10.1080/07448480009596296 11125642
18. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, Utzinger L, Fusillo S, J Am Acad Child Adolesc Psychiatry 2008 47 21 31 10.1097/chi.0b013e31815a56f1 18174822
19. Use of cognitive enhancement medication among northern italian university students. Castaldi S, Gelatti U, Orizio G, Hartung U, Moreno-Londono AM, Nobile M, Schulz PJ, J Addict Med 2012 6 112 117 10.1097/ADM.0b013e3182479584 22456492
20. Randomized response estimates for the 12-month prevalence of cognitive-enhancing drug use in university students. Dietz P, Striegel H, Franke AG, Lieb K, Simon P, Ulrich R, Pharmacotherapy 2013 33 44 50 10.1002/phar.1166 23307544
21. Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K, Pharmacopsychiatry 2011 44 60 66 10.1055/s-0030-1268417 21161883
22. Middendorf E, Poskowsky J, Isserstedt W, Formen der Stresskompensation und Leistungssteigerung bei Studierenden. HISBUS-Befragung zur Verbreitung und zu Mustern von Hirndoping und Medikamentenmissbrauch Hannover: HIS Hochschul-Informations-System GmbH 2012
23. What should we do about student use of cognitive enhancers? An analysis of current evidence. Ragan CI, Bard I, Singh I, Neuropharmacology 2013 64 588 595 22732441
24. Prevalence of stimulant use in a sample of US medical students. Webb JR, Valasek MA, North CS, Ann Clin Psychiatry 2013 25 27 32 23376867
25. Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. Forlini C, Racine E, BMC Med Ethics 2009 10 9 10.1186/1472-6939-10-9 19580661
26. "Adderall is definitely not a drug": justifications for the illegal use of ADHD stimulants. DeSantis AD, Hane AC, Subst Use Misuse 2010 45 31 46 10.3109/10826080902858334 20025437
27. Illicit use of prescription ADHD medications on a college campus: a multimethodological approach. DeSantis AD, Webb EM, Noar SM, J Am Coll Health 2008 57 315 324 10.3200/JACH.57.3.315-324 18980888
28. Australian university students' attitudes towards the use of prescription stimulants as cognitive enhancers: perceived patterns of use, efficacy and safety. Partridge B, Bell S, Lucke J, Hall W, Drug Alcohol Rev 2013 32 3 295 302 10.1111/dar.12005 23121045
29. Bryant A, Charmaz K, The SAGE Handbook of Grounded Theory London: Sage Publications 2010
30. Corbin J, Strauss A, Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory Thousand Oaks: Sage Publications 2008
31. Mayring P, Qualitative Inhaltsanalyse: Grundlagen und Techniken Landsberg: Beltz Verlag 2010
32. [Pharmacological neuroenhancement: Information and acceptance among students]. Hildt E, Franke AG, Lieb K, Nervenheilkunde 2011 10 833 837
33. Potential trends in attention deficit hyperactivity disorder (ADHD) drug use on a college campus: wastewater analysis of amphetamine and ritalinic acid. Burgard DA, Fuller R, Becker B, Ferrell R, Dinglasan-Panlilio MJ, Sci Total Environ 2013 450-451 242 249
34. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA, Am J Psychiatry 2007 164 942 948 10.1176/appi.ajp.164.6.942 17541055
35. Epidemiology of attention-deficit/hyperactivity disorder across the lifespan. Polanczyk G, Rohde LA, Curr Opin Psychiatry 2007 20 386 392 10.1097/YCO.0b013e3281568d7a 17551354